GF
XERS icon

Gabelli Funds’s Xeris Biopharma Holdings XERS Stock Holding History

Gabelli Funds’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198K Buy
+25,000
New +$160K ﹤0.01% 1182

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Gabelli Funds's XERS Position: Q2 2026 in Review

Gabelli Funds opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 25,000 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings.

239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Gabelli Funds held 25,000 shares of Xeris Biopharma Holdings worth $198K as of Q2 2026.
  • Xeris Biopharma Holdings was a new Gabelli Funds position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1182 holding.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.